Business plan teams hit quarter finals


"innovation" hot key on keyboard

Fourteen pharmacy student teams have progressed through to the quarter final round of the Pharmacy Guild of Australia’s annual National Student Business Plan Competition.

The competition is an Australia-wide challenge aiming to encourage and reward innovation among pharmacy students.

The 14 teams awarded places in the quarter finals are from nine Universities across Australia and New Zealand: La Trobe University, Charles Darwin University, Queensland University of Technology, University of Sydney, University of Technology Sydney, University of Queensland, Monash University, University of Tasmania and first time entrant University of Auckland.

Teams were required to develop two innovative services to implement in their pharmacies. One ‘new to the market’ or ‘highly differentiated’ from something already on offer, and one offering a social or community benefit.

Some of the innovative ideas included: travel health packs, a school education travelling van, a multi-lingual communication device, and the provision of food services that correlate to patients’ medical conditions

The quarter-final round commenced on 21 June and concludes on the 10 July 2016. The successful teams will progress to the semi-final round, and compete for a chance to be selected as finalists. Finalists receive complimentary registration, travel and accommodation to attend the Pharmacy Connect conference in Sydney in September.

The National Student Business Plan Competition is an initiative designed to promote creative entrepreneurship among pharmacy students and encourage the development of viable, innovative, pharmacist-owned community pharmacies, says the Guild.

It gives Australia’s best and brightest pharmacy students an opportunity to demonstrate their understanding of pharmacy practice through innovative and financially secure business models.

The competition is an initiative of the Pharmacy Guild of Australia and is proudly sponsored by Blackmores (Principal Sponsor), EBOS (Major Sponsor) Gold Cross Products and Services and Pharmaceutical Defence Limited.

Previous $22b health commitment lauded
Next Poll: how do you advise on topical corticosteroids?

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.